BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, April 26, 2026
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for July 8, 2022

July 8, 2022
New hires and promotions in the med-tech industry, including: Biolase.
Read More

Appointments and advancements for July 8, 2022

July 8, 2022
New hires and promotions in the biopharma industry, including: Cantargia, EMD Serono, Haemalogix, Kymera, Neuren, Ubiquigent.
Read More

Appointments and advancements for July 7, 2022

July 7, 2022
New hires and promotions in the med-tech industry, including: Ariceum Therapeutics, Rivanna.
Read More

Appointments and advancements for July 7, 2022

July 7, 2022
New hires and promotions in the biopharma industry, including: Ariceum, Emergent, Evolveimmune, Eyenovia, Kinaset, Piramal, Tevogen, Tscan, Ventus.
Read More

Appointments and advancements for July 6, 2022

July 6, 2022
New hires and promotions in the med-tech industry, including: Becton Dickinson, Blackrock Neurotech, Femasys.
Read More

Appointments and advancements for July 6, 2022

July 6, 2022
New hires and promotions in the biopharma industry, including: Ambrx, Aravive, Asher, Canbridge, Chemocentryx, Cornerstone, Cosette, Durect, Harpoon, Immunic, Intravacc, Kallyope, Nanoscope, Passage, Polypid, Scilex, Smart Immune.
Read More

Appointments and advancements for July 5, 2022

July 5, 2022
New hires and promotions in the med-tech industry, including: Annalise.ai, Sonendo.
Read More

Appointments and advancements for July 5, 2022

July 5, 2022
New hires and promotions in the biopharma industry, including: Alessa, Bioxcel, Celmatix, Coave, Eloxx, Lyra, Pharnext.
Read More

Appointments and advancements for July 1, 2022

July 1, 2022
New hires and promotions in the med-tech industry, including: Clario, Vivante Health, Zap Surgical.
Read More

Appointments and advancements for July 1, 2022

July 1, 2022
New hires and promotions in the biopharma industry, including: ADC, Affimed, Centessa, Clover, Fate, Infant Bacterial, Nektar, Newron, Protalix, Revir, Teva.
Read More
Previous 1 2 … 180 181 182 183 184 185 186 187 188 … 321 322 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 24, 2026.
  • Boy cupping ear with soundwave graphic

    A free gene therapy? Regeneron’s Otarmeni approved for hearing loss

    BioWorld
    Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
  • Illustration of a tumor

    Detecting the invisible: minimal residual disease at AACR 2026

    BioWorld Science
    Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
  • Illustration of metastatic cancer

    At AACR: Epigenetic fingerprints in metastases track tumor origin

    BioWorld
    When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
  • Illustration of human face that looks abstract and digital

    AACR 2026: The age of agentic AI in oncology

    BioWorld Science
    New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing